Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Abstract:

:Parkinson's disease (PD) is a chronic movement disorder typically coupled to progressive degeneration of dopaminergic neurons in the substantia nigra (SN). The treatments currently available are satisfactory for symptomatic management, but the efficacy tends to decrease as neuronal loss progresses. Neurotrophic factors (NTFs) are endogenous proteins known to promote neuronal survival, even in degenerating states. Therefore, the use of these factors is regarded as a possible therapeutic approach, which would aim to prevent PD or to even restore homeostasis in neurodegenerative disorders. Intriguingly, although favorable results in in vitro and in vivo models of the disease were attained, clinical trials using these molecules have failed to demonstrate a clear therapeutic benefit. Therefore, the development of animal models that more closely reproduce the mechanisms known to underlie PD-related neurodegeneration would be a major step towards improving the capacity to predict the clinical usefulness of a given NTF-based approach in the experimental setting. Moreover, some adjustments to the design of clinical trials ought to be considered, which include recruiting patients in the initial stages of the disease, improving the efficacy of the delivery methods, and combining synergetic NTFs or adding NTF-boosting drugs to the already available pharmacological approaches. Despite the drawbacks on the road to the use of NTFs as pharmacological tools for PD, very relevant achievements have been reached. In this article, we review the current status of the potential relevance of NTFs for treating PD, taking into consideration experimental evidence, human observational studies, and data from clinical trials.

journal_name

Drugs Aging

journal_title

Drugs & aging

authors

Rodrigues TM,Jerónimo-Santos A,Outeiro TF,Sebastião AM,Diógenes MJ

doi

10.1007/s40266-014-0160-x

subject

Has Abstract

pub_date

2014-04-01 00:00:00

pages

239-61

issue

4

eissn

1170-229X

issn

1179-1969

journal_volume

31

pub_type

杂志文章,评审
  • International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.

    abstract::Globally, the number of drug prescriptions is increasing causing more adverse drug events, which is now a significant cause of mortality, morbidity, and disability that has reached epidemic proportions. The risk of adverse drug events is correlated to very old age, multiple co-morbidities, dementia, frailty, and limit...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-018-0554-2

    authors: Mangin D,Bahat G,Golomb BA,Mallery LH,Moorhouse P,Onder G,Petrovic M,Garfinkel D

    更新日期:2018-07-01 00:00:00

  • Statin Use is Not Associated with Future Long-Term Care Admission: Extended Follow-Up of Two Randomised Controlled Trials.

    abstract:BACKGROUND:Statins have been associated with later life, long-term care admission in observational studies. However, by preventing vascular events, statins may also prevent or delay admission. We wished to determine statin and long-term care admission associations in a randomised controlled trial context, and describe ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,随机对照试验

    doi:10.1007/s40266-018-0560-4

    authors: Burton JK,Papworth R,Haig C,McCowan C,Ford I,Stott DJ,Quinn TJ

    更新日期:2018-07-01 00:00:00

  • Influenza vaccination in the elderly: impact on hospitalisation and mortality.

    abstract::Influenza causes substantial morbidity across the age spectrum. However, the elderly are especially vulnerable to the serious complications of influenza that might result in hospitalisation or death, and high rates of influenza-associated excess hospitalisation or death that exceed by several-fold the rates seen among...

    journal_title:Drugs & aging

    pub_type: 杂志文章,meta分析,评审

    doi:10.2165/00002512-200522060-00004

    authors: Nichol KL

    更新日期:2005-01-01 00:00:00

  • Diagnosis and treatment of patients with severe Alzheimer's disease.

    abstract::In contrast with the earlier stages and, in particular, the predementia stage, of Alzheimer's disease (AD), severe dementia is often neglected. However, the advanced stages of dementia are just as important as the earlier stages because of their frequency, their impact on the lives of patients and their caregivers, an...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/0002512-200926020-00005

    authors: Voisin T,Vellas B

    更新日期:2009-01-01 00:00:00

  • Polypharmacy and medication regimen complexity as factors associated with hospital discharge destination among older people: a prospective cohort study.

    abstract:BACKGROUND:Older people often take multiple medications. It is a policy priority to facilitate older people to stay at home longer. Three-quarters of nursing home placements in the US are preceded by a hospitalization. OBJECTIVE:To investigate the association between polypharmacy and medication regimen complexity with...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-014-0185-1

    authors: Wimmer BC,Dent E,Visvanathan R,Wiese MD,Johnell K,Chapman I,Bell JS

    更新日期:2014-08-01 00:00:00

  • Determination of digoxin clearance in Japanese elderly patients for optimization of drug therapy: a population pharmacokinetics analysis using nonlinear mixed-effects modelling.

    abstract:BACKGROUND:Optimal use of digoxin in the elderly population requires information about the drug's pharmacokinetics and the influence of various factors on the drug's disposition. However, because of sampling restrictions, it is often difficult to perform traditional pharmacokinetic studies in elderly patients. OBJECTI...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11594230-000000000-00000

    authors: Yukawa M,Yukawa E,Suematsu F,Takiguchi T,Ikeda H,Aki H,Mimemoto M

    更新日期:2011-10-01 00:00:00

  • Mechanisms of age-related endocrine alterations. Part II.

    abstract::Aging is associated with a myriad of hormonal changes. The mechanisms underlying these changes are variable. Aging is associated with anatomic changes of the endocrine glands, notably as a result of programmed cell death, autoimmune mediated destruction of the gland, or neoplastic transformation of glandular tissue. A...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199303020-00004

    authors: Mooradian AD

    更新日期:1993-03-01 00:00:00

  • Benzodiazepines and injurious falls in community dwelling elders.

    abstract:BACKGROUND:Benzodiazepines are frequently used medications in the elderly, in whom they are associated with an increased risk of falling, with sometimes dire consequences. OBJECTIVE:To estimate the impact of benzodiazepine-associated injurious falls in a population of elderly persons. METHOD:A nested case-control stu...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/00002512-200825010-00007

    authors: Pariente A,Dartigues JF,Benichou J,Letenneur L,Moore N,Fourrier-Réglat A

    更新日期:2008-01-01 00:00:00

  • Cyproterone. A review of its pharmacology and therapeutic efficacy in prostate cancer.

    abstract::Cyproterone (cyproterone acetate) is a steroidal antiandrogenic agent that inhibits the action of adrenal and testicular androgens on prostatic cells. Additionally, its progestogenic activity causes a centrally mediated reduction in testicular secretion of androgens. Studies have demonstrated the effectiveness of cypr...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199405010-00006

    authors: Barradell LB,Faulds D

    更新日期:1994-07-01 00:00:00

  • Impact of home patient telemonitoring on use of β-blockers in congestive heart failure.

    abstract:INTRODUCTION:Congestive heart failure (CHF), which typically affects older people, is characterized by high short- and mid-term mortality rates. However, despite accumulating evidence showing that administration of β-blockers (β-adrenoceptor antagonists) can improve the clinical status of CHF patients, use of these age...

    journal_title:Drugs & aging

    pub_type: 杂志文章,随机对照试验

    doi:10.2165/11538210-000000000-00000

    authors: Antonicelli R,Mazzanti I,Abbatecola AM,Parati G

    更新日期:2010-10-01 00:00:00

  • Colon cancer: a role for cyclo-oxygenase-2-specific nonsteroidal anti-inflammatory drugs.

    abstract::Large bowel cancer is not only the third most frequent cancer in the world but is one of the most common human malignancies in Western countries, including North America. In recent years, multidisciplinary research in epidemiology, molecular biology, and laboratory animal model studies have contributed much to our und...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200016050-00002

    authors: Reddy BS,Rao CV

    更新日期:2000-05-01 00:00:00

  • Current management strategies for hepatitis B in the elderly.

    abstract::Despite the availability of an efficient vaccine, chronic hepatitis B virus (HBV) infection remains a major public health problem worldwide. The World Health Organization estimates that there are still 350 million chronic carriers of the virus who are at risk of developing chronic hepatitis, liver cirrhosis and hepato...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200118100-00002

    authors: Merle P,Trépo C,Zoulim F

    更新日期:2001-01-01 00:00:00

  • Severity and management of drug-drug interactions in acute geriatric patients.

    abstract:BACKGROUND:Previous studies have investigated the prevalence of drug-drug interactions (DDIs) among the elderly in different care settings, but data describing the frequency and management of DDIs among acute geriatric patients appear to be absent. OBJECTIVE:The aim of this study was to investigate the severity and in...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-013-0091-y

    authors: Lea M,Rognan SE,Koristovic R,Wyller TB,Molden E

    更新日期:2013-09-01 00:00:00

  • Interventions to Improve Medicines Management for People with Dementia: A Systematic Review.

    abstract:BACKGROUND:The importance of optimising medicines management for people with dementia has been emphasised through research and policy. However, evidence is currently lacking regarding how to achieve this in this patient population. OBJECTIVE:The aim was to assess the effectiveness of medicines management interventions...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0505-3

    authors: McGrattan M,Ryan C,Barry HE,Hughes CM

    更新日期:2017-12-01 00:00:00

  • Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease.

    abstract::Parkinson's disease (PD) is the second most common neurodegenerative disorder affecting 1 to 3% of individuals over the age of 65 years. While effective therapy exists for treating the bradykinesia, rigidity and tremor associated with the disease, the cause is unknown. There is no treatment available to prevent or slo...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200118110-00001

    authors: Ross GW,Petrovitch H

    更新日期:2001-01-01 00:00:00

  • Inflammatory bowel disease in the elderly.

    abstract::Although inflammatory bowel disease (IBD) is generally considered a disease of young adults, it can occur in elderly individuals. The clinical features and treatment considerations in older patients are similar to those in younger patients, with some notable exceptions, which are reviewed in this article. Consideratio...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11537340-000000000-00000

    authors: Hussain SW,Pardi DS

    更新日期:2010-08-01 00:00:00

  • Epidemiology of adverse drug events in the nursing home setting.

    abstract::There is widespread concern about the level of use, particularly the inappropriate use, of drugs among elderly residents of nursing homes. Medication consumption by these individuals is among the highest of any patient population; residents of nursing homes are prescribed an average of 5 to 8 regularly scheduled medic...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199507030-00005

    authors: Monette J,Gurwitz JH,Avorn J

    更新日期:1995-09-01 00:00:00

  • Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness.

    abstract::The selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitor fluoxetine is an effective antidepressant in elderly patients. Its efficacy is similar to that of other frequently used antidepressants, such as the tricyclic antidepressants. However, compared with the tricyclic antidepressants, fluoxetine has a m...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199506010-00006

    authors: Harris MG,Benfield P

    更新日期:1995-01-01 00:00:00

  • Serotonin-norepinephrine reuptake inhibitor antidepressants and the risk of falls in older people: case-control and case-series analysis of a large UK primary care database.

    abstract:BACKGROUND:Antidepressant medications have long been implicated as a cause of falls in older people, but there are few data on the risk of falls associated with exposure to serotonin-norepinephrine (noradrenaline) reuptake inhibitors (SNRIs). OBJECTIVE:The aim of this study was to determine the role of SNRIs in older ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11592860-000000000-00000

    authors: Gribbin J,Hubbard R,Gladman J,Smith C,Lewis S

    更新日期:2011-11-01 00:00:00

  • A brief history of pneumococcal vaccines.

    abstract::Attempts to control pneumococcal infection by vaccination, undertaken initially in 1911, have gone through 3 phases during the subsequent 8 decades. Initially, vaccines of killed pneumococcal cells prepared in a variety of ways were used in epidemic settings with inconclusive results, although administered to approxim...

    journal_title:Drugs & aging

    pub_type: 历史文章,杂志文章

    doi:10.2165/00002512-199915001-00001

    authors: Austrian R

    更新日期:1999-01-01 00:00:00

  • Anaesthesia for cataract surgery.

    abstract::Cataract surgery is the most frequent surgical procedure requiring anaesthesia in developed countries. It is performed mainly in elderly patients, who present with many coexisting diseases that induce subsequent hazards from general anaesthesia. Cataract anaesthesia is performed following various techniques of regiona...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11318590-000000000-00000

    authors: Nouvellon E,Cuvillon P,Ripart J,Viel EJ

    更新日期:2010-01-01 00:00:00

  • Postinfarction use of beta-blockers in elderly patients.

    abstract::beta-Adrenoceptor antagonists (beta-blockers) reduce mortality and recurrent myocardial infarction (MI) in older patients after both Q-wave MI and non-Q-wave MI. The effects of beta-blockers are to: (i) reduce complex ventricular arrhythmias, including ventricular tachycardia; (ii) increase the ventricular fibrillatio...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199711060-00002

    authors: Aronow WS

    更新日期:1997-12-01 00:00:00

  • Spasticity after stroke. Epidemiology and optimal treatment.

    abstract::Spasticity following stroke reflects a spectrum of clinical problems including increased muscle tone, abnormal limb posture, excessive contraction of antagonist muscles and hyperactive cutaneous and tendon reflexes. The prevalence of stroke-related disability in stroke survivors is high, and spasticity may be a signif...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199609050-00004

    authors: O'Brien CF,Seeberger LC,Smith DB

    更新日期:1996-11-01 00:00:00

  • Etidronic acid. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.

    abstract::Etidronic acid is an orally and intravenously active bisphosphonate, which is believed to inhibit resorption of bone via a number of cellular mechanisms, including alteration of osteoclastic activity. In studies of patients with symptomatic Paget's disease, etidronic acid 5 to 20 mg/kg/day administered orally rapidly ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199405060-00006

    authors: Dunn CJ,Fitton A,Sorkin EM

    更新日期:1994-12-01 00:00:00

  • Anticholinergic medications: an additional contributor to cognitive impairment in the heart failure population?

    abstract:BACKGROUND/OBJECTIVES:Patients with congestive heart failure (CHF) have a high prevalence of cognitive impairment and the association is multifactorial. In general, the burden of anticholinergic drugs has consistently been shown to be a risk factor for cognitive impairment in the elderly. The aim of this study was to a...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-014-0204-2

    authors: Shaukat A,Habib A,Lane KA,Shen C,Khan S,Hellman YM,Boustani M,Malik AS

    更新日期:2014-10-01 00:00:00

  • Meglitinide analogues in the treatment of type 2 diabetes mellitus.

    abstract::Type 2 diabetes mellitus is a complex heterogenous metabolic disorder in which peripheral insulin resistance and impaired insulin release are the main pathogenetic factors. The rapid response of the pancreatic beta-cells to glucose is already markedly disturbed in the early stages of type 2 diabetes mellitus. The cons...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200017050-00007

    authors: Landgraf R

    更新日期:2000-11-01 00:00:00

  • Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunction.

    abstract::Intracavernous alprostadil (synthetic prostaglandin E1) is a vasodilating agent which acts by relaxing the smooth muscles of the corpus cavernosum and by increasing the diameter of cavernous arteries; this leads to erection. Following intracavernous administration, alprostadil is either locally metabolised or rapidly ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199608010-00009

    authors: Lea AP,Bryson HM,Balfour JA

    更新日期:1996-01-01 00:00:00

  • New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: focus on use in the elderly.

    abstract::NSAIDs are a widely used class of analgesic and anti-inflammatory drugs that act by inhibiting the cyclo-oxygenase (COX) enzyme. However, because of their nonspecificity of action, use of these agents as long-term therapy for chronic pain in diseases such as rheumatoid arthritis (RA) and osteoarthritis (OA) is often d...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200724060-00001

    authors: Bansal SS,Joshi A,Bansal AK

    更新日期:2007-01-01 00:00:00

  • Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs.

    abstract::Elderly rheumatoid arthritis (RA) is classified into two clinical subsets, elderly-onset RA (EORA) and younger-onset elderly RA. With the improvement of life expectancy in the general population and advent of the super-aging society, the number of patients with EORA is anticipated to increase. Both large and small joi...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-015-0341-2

    authors: Sugihara T,Harigai M

    更新日期:2016-02-01 00:00:00

  • Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

    abstract::Man and higher primates have adrenals that secrete large amounts of dehydroepiandrosterone (DHEA) [prasterone] and its sulphate (DHEAS) [PB 008]. A remarkable feature of plasma DHEAS levels in humans is their great decrease with aging. Researchers have postulated that this age-related decline of DHEAS levels may expla...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320130-00001

    authors: Legrain S,Girard L

    更新日期:2003-01-01 00:00:00